STEPHEN JONES: Open Payments
NPI 1124069240 · RAINBOW CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172 in 10 payments from 5 companies in 2025. Trend: 2023 $400 · 2024 $266 · 2025 $172
Food & beverage: $172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Novo Nordisk Inc | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: UBRELVY, AIRSUPRA, RELISTOR, Ozempic, Wegovy, Kerendia.
Industry payments across AL — which companies pay providers there.
